The latest research from Fore Pharma, Europe Parkinson’s Disease Market and Competitive Landscape – 2020, provides comprehensive insights into Parkinson’s Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Parkinson’s Disease market size and drug sales. It also provides insights into Parkinson’s Disease epidemiology and late stage pipeline.
This research covers the following – Parkinson’s Disease treatment options, Parkinson’s Disease late stage clinical trials pipeline, Parkinson’s Disease prevalence by countries, Parkinson’s Disease market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).
Research Scope:
– Countries: Germany, France, Italy, Spain, UK, Europe
– Parkinson’s Disease pipeline: Find out drugs in clinical trials for Parkinson’s Disease by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Parkinson’s Disease epidemiology: Find out number of patients diagnosed (prevalence) with Parkinson’s Disease by countries
– Parkinson’s Disease drugs: Identify key drugs marketed and prescribed for Parkinson’s Disease by countries, including trade name, molecule name, and company
– Parkinson’s Disease drugs sales: Find out the sales value for Parkinson’s Disease drugs by countries
– Parkinson’s Disease market valuations: Find out the market size for Parkinson’s Disease drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Parkinson’s Disease drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research: The research helps executives to
– Evaluate commercial market opportunities for Parkinson’s Disease drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Parkinson’s Disease market
– Develop in-depth knowledge of competition and markets
– Analyze Parkinson’s Disease drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Parkinson’s Disease market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies
Table of Contents
1. Parkinson’s Disease Treatment Options
2. Parkinson’s Disease Pipeline Insights
2.1. Parkinson’s Disease Phase 3 Clinical Trials
2.2. Parkinson’s Disease Phase 2 Clinical Trials
2.3. Parkinson’s Disease Phase 1 Clinical Trials
3. Parkinson’s Disease Epidemiology Analysis by Countries
4. Germany Parkinson’s Disease Market Insights
4.1. Marketed Drugs for Parkinson’s Disease in Germany
4.2. Germany Parkinson’s Disease Market Size & Forecast
4.3. Germany Parkinson’s Disease Drugs Sales Forecast
4.4. Germany Parkinson’s Disease Market Share Analysis
5. France Parkinson’s Disease Market Insights
5.1. Marketed Drugs for Parkinson’s Disease in France
5.2. France Parkinson’s Disease Market Size & Forecast
5.3. France Parkinson’s Disease Product Sales Forecast
5.4. France Parkinson’s Disease Market Share Analysis
6. Italy Parkinson’s Disease Market Insights
6.1. Marketed Drugs for Parkinson’s Disease in Italy
6.2. Italy Parkinson’s Disease Market Size & Forecast
6.3. Italy Parkinson’s Disease Product Sales Forecast
6.4. Italy Parkinson’s Disease Market Share Analysis
7. Spain Parkinson’s Disease Market Insights
7.1. Marketed Drugs for Parkinson’s Disease in Spain
7.2. Spain Parkinson’s Disease Market Size & Forecast
7.3. Spain Parkinson’s Disease Product Sales Forecast
7.4. Spain Parkinson’s Disease Market Share Analysis
8. UK Parkinson’s Disease Market Insights
8.1. Marketed Drugs for Parkinson’s Disease in UK
8.2. UK Parkinson’s Disease Market Size & Forecast
8.3. UK Parkinson’s Disease Product Sales Forecast
8.4. UK Parkinson’s Disease Market Share Analysis
9. Europe Parkinson’s Disease Market Insights
9.1. Europe Parkinson’s Disease Market Size & Forecast
9.2. Europe Parkinson’s Disease Product Sales Forecast
9.3. Europe Parkinson’s Disease Market Share Analysis
10. Research Methodology
List of Tables
1: Parkinson’s Disease Phase 3 Clinical Trials, Global, 2020
2: Parkinson’s Disease Phase 2 Clinical Trials, Global, 2020
3: Parkinson’s Disease Phase 1 Clinical Trials, Global, 2020
4: Parkinson’s Disease Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Parkinson’s Disease in Germany, 2019
6: Germany Parkinson’s Disease Market Size & Forecast ($mn), 2016 – 2025
7: Germany Parkinson’s Disease Product Sales ($mn), 2016 – 2025
8: Germany Parkinson’s Disease Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Parkinson’s Disease in France, 2019
10: France Parkinson’s Disease Market Size & Forecast ($mn), 2016 – 2025
11: France Parkinson’s Disease Product Sales ($mn), 2016 – 2025
12: France Parkinson’s Disease Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Parkinson’s Disease in Italy, 2019
14: Italy Parkinson’s Disease Market Size & Forecast ($mn), 2016 – 2025
15: Italy Parkinson’s Disease Product Sales ($mn), 2016 – 2025
16: Italy Parkinson’s Disease Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Parkinson’s Disease in Spain, 2019
18: Spain Parkinson’s Disease Market Size & Forecast ($mn), 2016 – 2025
19: Spain Parkinson’s Disease Product Sales ($mn), 2016 – 2025
20: Spain Parkinson’s Disease Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Parkinson’s Disease in UK, 2019
22: UK Parkinson’s Disease Market Size & Forecast ($mn), 2016 – 2025
23: UK Parkinson’s Disease Product Sales ($mn), 2016 – 2025
24: UK Parkinson’s Disease Market Events and Trends, 2016 – 2025
25: Europe Parkinson’s Disease Market Size & Forecast ($mn), 2016 – 2025
26: Europe Parkinson’s Disease Product Sales ($mn), 2016 – 2025
List of Figures
1: Parkinson’s Disease Pipeline by Phase (%), Global, 2020
2: Parkinson’s Disease Prevalence by Countries, 2016 – 2025
3: Germany Parkinson’s Disease Market Size ($mn), 2016 – 2025
4: Germany Parkinson’s Disease Product Sales ($mn), 2016 – 2025
5: Germany Parkinson’s Disease Market Share by Drugs (%), 2019
6: Germany Parkinson’s Disease Market – Future Market Share (%), 2025
7: France Parkinson’s Disease Market Size ($mn), 2016 – 2025
8: France Parkinson’s Disease Product Sales ($mn), 2016 – 2025
9: France Parkinson’s Disease Market Share by Drugs (%), 2019
10: France Parkinson’s Disease Market – Future Market Share (%), 2025
11: Italy Parkinson’s Disease Market Size ($mn), 2016 – 2025
12: Italy Parkinson’s Disease Product Sales ($mn), 2016 – 2025
13: Italy Parkinson’s Disease Market Share by Drugs (%), 2019
14: Italy Parkinson’s Disease Market – Future Market Share (%), 2025
15: Spain Parkinson’s Disease Market Size ($mn), 2016 – 2025
16: Spain Parkinson’s Disease Product Sales ($mn), 2016 – 2025
17: Spain Parkinson’s Disease Market Share by Drugs (%), 2019
18: Spain Parkinson’s Disease Market – Future Market Share (%), 2025
19: UK Parkinson’s Disease Market Size ($mn), 2016 – 2025
20: UK Parkinson’s Disease Product Sales ($mn), 2016 – 2025
21: UK Parkinson’s Disease Market Share by Drugs (%), 2019
22: UK Parkinson’s Disease Market – Future Market Share (%), 2025
23: Europe Parkinson’s Disease Market Size ($mn), 2016 – 2025
24: Europe Parkinson’s Disease Product Sales ($mn), 2016 – 2025
25: Europe Parkinson’s Disease Market Share by Drugs (%), 2019
26: Europe Parkinson’s Disease Market – Future Market Share (%), 2025
Format
Dispatch format is XLSX.